Literature DB >> 26141194

Role of EphA4 signaling in the pathogenesis of amyotrophic lateral sclerosis and therapeutic potential of traditional Chinese medicine rhynchophylline.

Kenji Hashimoto1.   

Abstract

Entities:  

Year:  2015        PMID： 26141194     DOI： 10.1007/s00213-015-4013-z

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN： 0033-3158            Impact factor:   4.530


× No keyword cloud information.
  7 in total

Review 1.  Therapeutic targeting of EPH receptors and their ligands.

Authors:  Andrew W Boyd; Perry F Bartlett; Martin Lackmann
Journal:  Nat Rev Drug Discov       Date:  2014-01       Impact factor: 84.694

2.  Blockade of EphA4 signaling ameliorates hippocampal synaptic dysfunctions in mouse models of Alzheimer's disease.

Authors:  Amy K Y Fu; Kwok-Wang Hung; Huiqian Huang; Shuo Gu; Yang Shen; Elaine Y L Cheng; Fanny C F Ip; Xuhui Huang; Wing-Yu Fu; Nancy Y Ip
Journal:  Proc Natl Acad Sci U S A       Date:  2014-06-23       Impact factor: 11.205

Review 3.  Antihypertensive and neuroprotective activities of rhynchophylline: the role of rhynchophylline in neurotransmission and ion channel activity.

Authors:  Jiyin Zhou; Shiwen Zhou
Journal:  J Ethnopharmacol       Date:  2010-08-22       Impact factor: 4.360

4.  Efficacy and safety of yokukansan in treatment-resistant schizophrenia: a randomized, double-blind, placebo-controlled trial (a Positive and Negative Syndrome Scale, five-factor analysis).

Authors:  Tsuyoshi Miyaoka; Motohide Furuya; Jun Horiguchi; Rei Wake; Sadayuki Hashioka; Masaya Tohyama; Norio Mori; Yoshio Minabe; Masaomi Iyo; Shyuichi Ueno; Sachiko Ezoe; Kenta Murotani; Syuzo Hoshino; Haruo Seno
Journal:  Psychopharmacology (Berl)       Date:  2014-06-13       Impact factor: 4.530

Review 5.  Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND).

Authors:  Robert G Miller; J D Mitchell; Dan H Moore
Journal:  Cochrane Database Syst Rev       Date:  2012-03-14

6.  EPHA4 is a disease modifier of amyotrophic lateral sclerosis in animal models and in humans.

Authors:  Annelies Van Hoecke; Lies Schoonaert; Robin Lemmens; Mieke Timmers; Kim A Staats; Angela S Laird; Elke Peeters; Thomas Philips; An Goris; Bénédicte Dubois; Peter M Andersen; Ammar Al-Chalabi; Vincent Thijs; Ann M Turnley; Paul W van Vught; Jan H Veldink; Orla Hardiman; Ludo Van Den Bosch; Paloma Gonzalez-Perez; Philip Van Damme; Robert H Brown; Leonard H van den Berg; Wim Robberecht
Journal:  Nat Med       Date:  2012-09       Impact factor: 53.440

Review 7.  Yokukan-san: a review of the evidence for use of this Kampo herbal formula in dementia and psychiatric conditions.

Authors:  Hideki Okamoto; Masaomi Iyo; Keigo Ueda; Cheolsun Han; Yoshiro Hirasaki; Takao Namiki
Journal:  Neuropsychiatr Dis Treat       Date:  2014-09-12       Impact factor: 2.570
  7 in total
  2 in total

1.  Decreased signalling of EphA4 improves functional performance and motor neuron survival in the SOD1G93A ALS mouse model.

Authors:  J Zhao; L T Cooper; A W Boyd; P F Bartlett
Journal:  Sci Rep       Date:  2018-07-30       Impact factor: 4.379

2.  Increased EphA4-ephexin1 signaling in the medial prefrontal cortex plays a role in depression-like phenotype.

Authors:  Ji-Chun Zhang; Wei Yao; Youge Qu; Mayumi Nakamura; Chao Dong; Chun Yang; Qian Ren; Min Ma; Mei Han; Yukihiko Shirayama; Akiko Hayashi-Takagi; Kenji Hashimoto
Journal:  Sci Rep       Date:  2017-08-02       Impact factor: 4.379
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.